Related Experiment Video
Updated: Feb 8, 2026

08:09
Generation of Human Brain Organoids for Mitochondrial Disease Modeling
Published on: June 21, 2021
6.8K
Modeling Neurological Diseases With Human Brain Organoids
1Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Frontiers in Synaptic Neuroscience
|June 26, 2018
Summary
Human brain organoids, derived from pluripotent stem cells, offer a powerful model for studying brain development and neurological disorders. This review highlights their advances and applications in disease modeling and therapeutic discovery.
Area of Science:
- Neuroscience
- Developmental Biology
- Stem Cell Research
Background:
- The human brain's complexity poses challenges for studying its development, function, and disorders.
- Human pluripotent stem cells (PSCs) offer a potential source for modeling brain biology.
- Brain organoids are emerging as a valuable tool for in vitro modeling of the human brain.
Purpose of the Study:
- To review recent advancements in human brain organoid systems.
- To explore the application of brain organoids in modeling neurological diseases.
- To discuss the limitations and future prospects of brain organoids in disease modeling and therapeutic discovery.
Main Methods:
- Review of current literature on human brain organoid generation and application.
- Analysis of studies utilizing brain organoids for modeling neurological disorders.
- Discussion of therapeutic strategies explored using brain organoid models.
Main Results:
- Human brain organoids derived from PSCs provide a viable model for recapitulating aspects of human brain development.
- Brain organoids are increasingly utilized for modeling various neurological disorders.
- These organoids show promise in facilitating the discovery of novel therapeutic interventions.
Conclusions:
- Human brain organoids represent a significant breakthrough in studying brain biology and diseases.
- Continued development and application of brain organoids are crucial for advancing our understanding of neurological conditions.
- Addressing current limitations will further enhance the utility of brain organoids in future research and clinical applications.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases
2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.4K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Principles of Disease Surveillance
563
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
563
Psychoneuroimmunology: Cardiovascular Disease
580
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
580

